Facebook Linkedin RSS Twitter Youtube
Home 2023

Government policy making

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers
Drug Discovery

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease
Genome Editing

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin
Drug Discovery

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform
Bioprocessing

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform

CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease
Genome Editing

CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease

How Church and Langer Make the Impossible Possible
Drug Discovery

How Church and Langer Make the Impossible Possible

Machine Learning for Process Validation
Bioprocessing

Machine Learning for Process Validation

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals
Industry News

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals

European Commission Orders Illumina to Divest of Grail
Industry News

European Commission Orders Illumina to Divest of Grail

Strengthening the Flow of the Biotech Sector’s M&A Pipeline
Industry News

Strengthening the Flow of the Biotech Sector’s M&A Pipeline

123...16Page 1 of 16
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.